|
 |
The year that was! Round up 2007
 |
|
| Year 2007 can easily be classified as the turning point for the life sciences industry. It saw the completion of the second phase of HapMap Projectcreated to identify and catalog genetic similarities and differences among populations around the world |
|
 |
|
|
| |
| Vietnam pharma market opens up
|
|
| Vietnams entry into WTO in 2007 has boosted the fortunes of the local pharmaceutical industry and has created confidence among the MNC pharma companies and investors |
|
|
|
|
| |
| 'We are bullish on India':Perkin Elmers
|
|
| Asia Pacific makes for about 20 percent of our revenue and about 40 percent of our people are based in the Asia Pacific region. The percentage of people will grow because we are investing ahead of the demand, and this region is growing faster |
|
|
|
|
| |
|
|
| |
| Jubilant is India's largest CRAMS player
|
|
| India nevertheless retains relevance as a growing source of research and contract manufacturing. Its low-cost manufacturing, inexpensive English-speaking labor, and advanced chemistry expertise remain attractive to pharma MNCs seeking to cut costs |
|
|
|
|
| |
| We are building a bio-engineering company:CSKI
|
|
| China Sky One Medical (CSKI), a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal kit products |
|
|
|
|
| |
|
|
| |
| TCM gains ground
|
|
| The popularity of TCM has been gaining ground since last few yearsand not just in Asia but in the US and Europe as well |
|
|
|
|
| |
| Challenges for the services segment
|
|
| Mark Ravera is a principal of Strategic Pharma Consulting Group, which provides advisory services to both emerging market and western biopharmaceutical companies. This work makes him a frequent visitor to Asia |
|
|
|
|
| |
| Stem cell therapies to hit market soon
|
|
| Going by the research and commercialization efforts underway in the industry, it wont be long before stem cell therapy would be commonplace. The next 10 years will see a number of initiatives in that direction |
|
|
|
|
| More |
SITE MAP 
